AAD VMX 2021 Experts Say Teledermatology's Post-Pandemic Role Is Unclear There are many unknowns, not least of which is future reimbursement from the Centers for Medicare & Medicaid Services and other ...
AAD VMX 2021 Novel S1P-Receptor Modulator Shows Promise in Phase 2b AD Trial 'This was a short proof-of-concept study to show this mechanism is valid. The results are promising,' said Dr Emma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results